February 13th, 2011
The Boston Globe ran a story last week which debunks a few myths about American manufacturing. It touches on the decline of American manufacturing (false!) and the loss of jobs to China due to lower wages (false!). Conclusion: American companies are manufacturing more than ever, but doing so with fewer workers. It isn’t the Chinese stealing our jobs – it’s the machines!
The “decline of US manufacturing’’ is giving Americans a “sense of economic precariousness’’ — only one in . . .
→ Read More: Debunking US Manufacturing Myths
February 7th, 2011
I came across this video today that features Martin Lipton, senior partner of Wachtell, Lipton, Rosen & Katz and creator of the Poison Pills in the 1980s. I have discussed poison pills in a few places on this site because these frequently arise for value investors when portfolio companies become the target of a takeover. Depending on how you view poison pills, they either delay or enhance the value received.
Talk to Frank . . .
→ Read More: Inventing the Poison Pill
February 5th, 2011
FOR IMMEDIATE RELEASE: SILENT KILLER CLAIMS NEARLY 9,000 AMERICAN LIVES ANNUALLY
Earlier this year that Nina E. Olson, the ombudsman for the Internal Revenue Service, reported that Americans are spending 6.1 billion hours preparing their tax returns each year – the equivalent of 2,932,692 Americans working full time. 6.1 billion hours per year equates to the equivalent of 695,884.7 years (accounting for leap years of course). The World Bank reports that the average lifespan . . .
→ Read More: Silent Killer Claims Nearly 9,000 American Lives Annually
January 28th, 2011
ValueWalk.com has a great post showing a heat map of market valuations worldwide, based on data from Damodaran. It factors in all public US firms and all non-US firms with market caps greater than $5m Pretty interesting stuff. Check it out here: World Valuation Heat Map.
Talk to Frank about Market Values
January 27th, 2011
MagicDiligence has an interesting article about combining a technical indicator (price momentum) with fundamental value metrics (those exhibited by Greenblatt’s Magic Formula).
What was more surprising were his findings on price momentum, defined in the book as high trailing twelve month stock price appreciation. The stocks with the best price momentum greatly outperformed the market, although doing so with high volatility. On the other hand, buying the stocks with the worst price momentum was a sure path to . . .
→ Read More: Combining Technicals with Fundamentals
|
|